Literature DB >> 10777678

The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane.

E Rocchi1, A Khodjakov, E L Volk, C H Yang, T Litman, S E Bates, E Schneider.   

Abstract

The products of the ABC gene family can be generally classified as either full-transporters of half-transporters. Full-transporters are expressed in the plasma membrane, whereas half-transporters are usually found in intracellular membranes. Recently, an ABC half-transporter, the ABCG2 gene product Breast Cancer/Mitoxantrone Resistance Protein (BCRP/MXR), has been shown to cause mitoxantrone and topotecan resistance. The purpose of this study was to determine the expression and the intracellular localization of this protein in various drug-resistant cell lines. BCRP/MXR expression was determined by Western blot and immunohistochemistry. This protein is highly overexpressed in several drug-resistant cell lines and localizes predominantly to the plasma membrane, instead of to intracellular membranes as seen with all other known half-transporters. Therefore, BCRP/MXR is unique among the ABC half-transporters by being localized to the plasma membrane. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777678     DOI: 10.1006/bbrc.2000.2590

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

Review 1.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

Review 2.  Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease.

Authors:  Jens Pahnke; Olaf Wolkenhauer; Markus Krohn; Lary C Walker
Journal:  Curr Alzheimer Res       Date:  2008-08       Impact factor: 3.498

Review 3.  Specific protein markers for stem cell cross-talk with neighboring cells in the environment.

Authors:  Kyung Soo Park; Seung Won Shin; Jeong-Woo Choi; Soong Ho Um
Journal:  Int J Stem Cells       Date:  2013-11       Impact factor: 2.500

Review 4.  The role of half-transporters in multidrug resistance.

Authors:  S E Bates; R Robey; K Miyake; K Rao; D D Ross; T Litman
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

Review 5.  An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.

Authors:  Lyrialle W Han; Chunying Gao; Qingcheng Mao
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-08-03       Impact factor: 4.481

6.  Principles and Experimental Considerations for In Vitro Transporter Interaction Assays.

Authors:  Sid Bhoopathy; Chris Bode; Vatsala Naageshwaran; Erica Weiskircher-Hildebrandt; Venkata Mukkavilli; Ismael J Hidalgo
Journal:  Methods Mol Biol       Date:  2021

7.  Oncogenic retinoic acid receptor γ knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/β-catenin pathway.

Authors:  Gui-Li Huang; Wei Song; Pan Zhou; Qi-Rui Fu; Chen-Lu Lin; Qing-Xi Chen; Dong-Yan Shen
Journal:  Cell Cycle       Date:  2017-03-08       Impact factor: 4.534

8.  BCRP protein levels do not differ regionally in adult human livers, but decline in the elderly.

Authors:  Zoe Riches; Ngu Abanda; Abby C Collier
Journal:  Chem Biol Interact       Date:  2015-10-14       Impact factor: 5.192

9.  Role of the breast cancer resistance protein (ABCG2) in drug transport.

Authors:  Qingcheng Mao; Jashvant D Unadkat
Journal:  AAPS J       Date:  2005-05-11       Impact factor: 4.009

Review 10.  Drug transporters in the human blood-placental barrier.

Authors:  Kirsi Vähäkangas; Päivi Myllynen
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.